Background: Parvovirus B19 is the agent causing a regenerative anemia in\norgan transplant recipients, due to their immunodepressive status. The diagnosis\nis usually confirmed by the presence of virus in the blood and bone\nmarrow via the PCR technique. There is a potential co-infection with other\nopportunistic viruses in the transplanted patients. However, this population is\nnot routinely screened for Parvovirus B19 infection. Case Report: A\n14-year-old male patient who received living-donor kidney transplantation\ndeveloped a severely progressive and aregenerative anemia four weeks later.\nPCR of Parvovirus B19 was positive from bone marrow aspiration. There\nwere concomittant CMV and BK virus co-infection. The treatment included\na reduction of immunosuppressants, intravenous gamma globulin.\nValganciclovir has been prescribed for three months that could negativate the\nCMV blood load. At the end, there was an eradication of parvovirus in the\nbone marrow. Conclusion : This first reported case in Viet Nam which informed\nthat infection with Parvovirus B19 should be investigated in the\ntransplanted population when a regenerative anemia is present. Otherwise, a\nscreening strategy for Parvovirus B19 should also be considered.
Loading....